Postoperative Nausea and Vomiting after Myringoplasty under Continuous Sedation Using Midazolam with or without Remifentanil
Yonsei Medical Journal
;
: 1010-1013, 2012.
Article
in English
| WPRIM
| ID: wpr-228768
ABSTRACT
PURPOSE:
This prospective study evaluated the effects of continuous sedation using midazolam, with or without remifentanil, on postoperative nausea and vomiting (PONV) in patients undergoing myringoplasty. MATERIALS ANDMETHODS:
Sixty patients undergoing myringoplasty were sedated with midazolam in the presence of remifentanil (group MR), or after saline injection instead of remifentanil (group M).RESULTS:
Three patients (10%) in group M complained of nausea; two vomited. Four patients (13%) in group MR complained of nausea and vomited within 24 h after surgery. Rescue drugs were given to the six patients who vomited. No significant difference was detected between the two groups regarding the incidence or severity of nausea, incidence of vomiting, or need for rescue drugs.CONCLUSION:
Midazolam-based continuous sedation can reduce PONV after myringoplasty. Compared with midazolam alone, midazolam with remifentanil produced no difference in the incidence or severity of nausea, incidence of vomiting, or need for rescue drugs.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Vomiting
/
Midazolam
/
Incidence
/
Prospective Studies
/
Postoperative Nausea and Vomiting
/
Myringoplasty
/
Nausea
Type of study:
Incidence study
/
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Yonsei Medical Journal
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS